- 1Near East University School Of Medicine, Department Of Ophthalmology, Lefkosa, Kibris
Sorumlu Yazar: Bilateral optic disc edema in the presence of normal optic nerve function frequently indicates an increased ICP. Diagnosis of IIH is based on symptoms and signs attributable to increased ICP, elevated CSF pressure, normal CSF profiles in the absence of ventriculomegaly, mass, or vascular lesions on neuroimaging, and no other etiology of intracranial hypertension identified.9 However, various other probable causes of increased ICP should be considered including benign or malignant mass lesions of the brain, venous sinus thrombosis, infectious, inflammatory and malignant disorders involving the meninges. In this instance, a previously healthy young woman developed visual obscurations. Given the appearance of bilateral papilledema, increased ICP with or without a space-occupying lesion was a prime suspicion. In view of the visual symptoms and fundus appearance without other focal neurologic signs in a young woman, IHH should be the top differential. IHH is not a rare disease. Population-based studies have documented annual incidence rates of 1-2 per 100000 people.10 The pathophysiology of IIH is still unknown.2 There are various proposed hypotheses for the IHH which are mostly concerning deranged CSF homeostasis, and include diffuse brain edema, excessive CSF production, reduced CSF absorption, and increased cerebral venous pressure, which all require further elucidation.2,4 Various conditions also have been implicated in IIH.2 Case reports have associated IIH with iron deficiency anemia, hypothyroidism, polycystic ovary syndrome, and use of steroids, vitamin A, and oral contraceptives, however, apart from female sex, recent weight gain, and obesity, there are no proven associations.2-4 The report concerning diagnostic criteria for IIH has proposed that the lumbar opening pressure should be greater than 250 mm of water measured with the patient in the lateral decubitus position.11 The values between 200 and 250 mm of water are accepted as nondiagnostic.12 However, LP may provide an inaccurate measure of ICP, given its known moment-to-moment fluctuations and the effects on ICP of straining, positioning, and pharmacologic sedation.13 The CSF pressure naturally fluctuates just like intraocular pressure. Although we recommended a repeat LP which is usually necessary if the opening pressure is low in the appropriate clinical settings to prevent obtaining the false negative test results because of the fluctuation phenomena, the patient refused the repeat LP measurements with insistence. In this manner, we had to diagnose this patient empirically. The clinical picture of the optic nerve heads, symptoms of patient and the prompt response of patient to typical IIH treatment were all strong indicators that this patient could be accepted as IIH. Furthermore, the generally accepted normal range in adults is 80–200 mm of water.14 In this case, we could not classify this patient’s CSF pressure as within normal limits. There are some questionnaires to identify the symptoms and coexisting medical conditions associated with IIH.15 Ninety percent of the IIH patients were women; the mean age was 33. Obesity and recent weight gain were much more common among patients than controls. Symptoms most commonly reported by IIH patients were headache (94%), transient visual obscurations (TVO) (68%), and intracranial noises (ICN) (58%). Other common symptoms observed in IIH included photopsia (54%), diplopia (38%), and visual loss (30%).15 Daily occurrence of these symptoms was much more common among patients than controls. Controls also reported these and other IIH symptoms, but at lower frequencies. Several conditions previously associated with IIH were no more common in patients than in controls including iron deficiency anemia, thyroid disease, pregnancy, antibiotic intake, and use of oral contraceptives. We conclude that previous studies of IIH, mostly uncontrolled and retrospective, have underestimated the frequency of symptoms in IIH patients and reported chance and spurious associations with common medical conditions and medications. Radhakrishnan et al. presented a variety of additionally described risk factors of varying strength, including the coexistence of endocrinopathies, menstrual irregularities, autoimmune disorders, chronic renal failure, and concurrent medication use - such as steroids, estrogens, vitamin A, thyroid supplements and antibiotics - among patients with IIH.16 These authors have suggested that patients developing IIH may possess an underlying abnormality or predisposition which, when acting in concert with an aggravating agent such as recent weight gain or antibiotic use, produces the disease. Papilledema and optic nerve sheath enlargement can be seen with IIH.17,18 There are some common features of both diseases; however, there is no significant evidence suggesting the role of raised intracranial pressure in the etiology of the dural ectasia of the optic nerve4,19 Although optic nerve sheath dilation is one of the radiological features of IIH, the enlargement of the optic nerve sheath to the degree we found in our patient is unusual. A rare case of dural ectasia of the optic nerve sheath have also been reported. In this case, a 36-year-old woman with a 3-month history of progressive visual loss had papilledema , dilatation of optic nerve sheath, and normal CSF pressure; she had been treated with acetazolamide 250 mg qid for 8 weeks elsewhere. LP was performed with an opening pressure of 22 cm of water and the CSF pressure at repeat LP was significantly low which could not be recorded.20 MRI is mostly performed to exclude other intracranial pathologies which may increase ICP. However, MRI may exhibit radiographic evidence of increased ICP, which includes slit ventricle, empty sella, flattening of the posterior sclera, distension of the perioptic subarachnoid space, tortuous optic nerve, protrusion and enhancement of the optic disc. Endocrine dysfunction is a rare but known cause of IIH in adults. A rare case of IIH in the pediatric age group associated with autoimmune hyperthyroidism have also been reported.21 In this case, a 12-year-old girl presented with a 3-month history of headaches. Ophthalmic examination revealed bilateral papilledema. The ocular findings were otherwise normal, with no exophthalmos. Cranial and orbital MRI was unremarkable. Lumbar CSF opening pressure in recumbent and relaxed position was elevated (31 cm water). Thyroid hormones ( fT3 and fT4) were elevated, while TSH was completely suppressed. As TSH receptor stimulating antibodies (TSHR-Ab) were elevated, Graves’ disease was diagnosed. Thyroid suppressive therapy with carbimazole was initiated and supplemented by propranolol. As hyperthyroidism improved over two weeks, the headaches subsided, and the papilledema slowly resolved over the next 2 months. This case illustrates that hyperthyroidism should be considered as a cause of IIH in children. In summary, our case is an IIH associated with unilateral proptosis and bilateral prominent dural ectasia. To our knowledge, this is the first case reported with these associated pathologies toget her. Although the proptosis may be the only sign of the euthyroid Graves’ disease and thus patient may have an endocrine dysfunction, we could not detect this clinically and serologically. In this condition, we thought that this case with these isolated pathologies should be reported for providing an additional information for the IIH literature. Address for Correspondence/Yazisma Adresi: Serkan Dagdelen MD, Near East University School of Medicine, Department of Ophthalmology, Lefkosa, Kibris Gsm: +90 533 823 94 44 E-mail: drserkand4@yahoo.com Received/Gelis Tarihi: 22.06.2012 Accepted/Kabul Tarihi: 03.10.2012
Bu dergide yayımlanan makalelerde yer alan ifadeler, görüşler ve veriler yalnızca ilgili yazar(lar)a ve katkı sağlayan kişilere aittir; derginin, editörlerin, yayın kurulunun, dergi sahibinin veya Galenos Yayınevi’nin görüşlerini zorunlu olarak yansıtmaz.
Dergi ve Galenos Yayınevi, dergide adı geçen veya reklamı yapılan herhangi bir ticari ürün, süreç, hizmet, kurum veya kuruluşu onaylamaz ya da tavsiye etmez. Reklamların, ürün bilgilerinin veya harici internet sitesi bağlantılarının yayımlanması, dergi veya yayınevi tarafından bunların onaylandığı ya da desteklendiği anlamına gelmez.
Dergi, editörleri, yayın kurulu, dergi sahibi ve Galenos Yayınevi yayımlanan içeriğin doğruluğunu ve bilimsel bütünlüğünü sağlamak için makul özeni göstermekle birlikte, yürürlükteki mevzuatın izin verdiği ölçüde, içerikte bulunabilecek hata veya eksikliklerden ya da yayımlanan bilgilerin kullanımından kaynaklanabilecek sonuçlardan sorumlu tutulamaz.
Dergide yayımlanan bilgiler bilimsel ve eğitsel amaçlıdır ve profesyonel tıbbi görüş, tanı veya tedavinin yerine geçmez. Bireysel sağlık durumları veya tedavi kararları konusunda uygun niteliklere sahip sağlık profesyonellerine danışılması önerilir.
Harici internet sitesi bağlantıları yalnızca bilgilendirme ve kullanım kolaylığı amacıyla sunulmaktadır. Dergi ve Galenos Yayınevi, harici internet sitelerinin erişilebilirliğinden, doğruluğundan, içeriğinden, gizlilik uygulamalarından veya politikalarından sorumlu değildir.